Literature DB >> 11191974

Who gets alcoholic liver disease: nature or nurture?

C P Day1.   

Abstract

The factors determining why fewer than 10% of drinkers develop advanced alcoholic liver disease remain largely unknown. There is a weak relationship between disease risk and the dose and pattern of alcohol consumed. Obesity increases the risk of all stages of alcoholic liver disease, probably reflecting the role of steatosis in the pathogenesis of more advanced disease. Women develop disease at a lower intake than men due, in part, to their lower volume of distribution for alcohol, but also potentially to increased gut permeability to endotoxin. Recent studies suggest a non-gender-linked genetic component to disease susceptibility and recent case-control studies have suggested that polymorphisms of genes encoding cytokines and other immunoregulatory molecules may exert a significant effect. The pattern of polymorphisms associated with risk suggests that antibody-mediated mechanisms play a role in disease pathogenesis. This has implications for treatment and for identifying high risk individuals at an early stage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191974

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  13 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  Histopathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

Review 3.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 4.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Silencing a killer among us: ethanol impairs immune surveillance of activated stellate cells by natural killer cells.

Authors:  Gavin E Arteel
Journal:  Gastroenterology       Date:  2008-01       Impact factor: 22.682

6.  Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice.

Authors:  Andrew M Miller; Hua Wang; Adeline Bertola; Ogyi Park; Norio Horiguchi; Sung Hwan Ki; Shi Yin; Fouad Lafdil; Bin Gao
Journal:  Hepatology       Date:  2011-09-02       Impact factor: 17.425

7.  Hepatic sinusoidal endothelium avidly binds platelets in an integrin-dependent manner, leading to platelet and endothelial activation and leukocyte recruitment.

Authors:  Patricia F Lalor; John Herbert; Roy Bicknell; David H Adams
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-20       Impact factor: 4.052

Review 8.  Alcoholic disease: liver and beyond.

Authors:  Alba Rocco; Debora Compare; Debora Angrisani; Marco Sanduzzi Zamparelli; Gerardo Nardone
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

9.  Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999-2018.

Authors:  Young-Hee Yoon; Chiung M Chen; Megan E Slater; M Katherine Jung; Aaron M White
Journal:  Am J Prev Med       Date:  2020-08-27       Impact factor: 5.043

Review 10.  New role of plasminogen activator inhibitor-1 in alcohol-induced liver injury.

Authors:  Gavin E Arteel
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.